Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Usana Health Sciences (USNA) Debt to Equity (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Debt to Equity for 6 consecutive years, with $0.04 as the latest value for Q1 2025.

  • On a quarterly basis, Debt to Equity rose 1544.5% to $0.04 in Q1 2025 year-over-year; TTM through Mar 2025 was $0.04, a 1544.5% increase, with the full-year FY2024 number at $0.04, up 2634.25% from a year prior.
  • Debt to Equity was $0.04 for Q1 2025 at Usana Health Sciences, roughly flat from $0.04 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $0.04 in Q1 2025 to a low of $0.0 in Q4 2023.
  • A 4-year average of $0.02 and a median of $0.03 in 2022 define the central range for Debt to Equity.
  • Peak YoY movement for Debt to Equity: soared 2634.25% in 2024, then soared 1544.5% in 2025.
  • Usana Health Sciences' Debt to Equity stood at $0.03 in 2022, then tumbled by 93.84% to $0.0 in 2023, then skyrocketed by 2634.25% to $0.04 in 2024, then increased by 0.44% to $0.04 in 2025.
  • Per Business Quant, the three most recent readings for USNA's Debt to Equity are $0.04 (Q1 2025), $0.04 (Q4 2024), and $0.0 (Q1 2024).